Texas Student Won Award for Clam Cancer Research
A 17-year-old resident of The Woodlands utilized a clam model to test drug combinations for blood-cancer treatment.
Updated on Oct. 13, 2026 in Cancer
Live Poll
Should unconventional research methods be prioritized alongside traditional scientific laboratory models?
Iris Shen of The Woodlands, Texas, earned third place and a $150,000 prize in the 2026 Regeneron Science Talent Search. The 17-year-old student investigated the use of clams as a novel animal model to screen drug combinations for potential blood-cancer treatments.
Why it matters
Identifying affordable and ethical animal models like clams could streamline the screening of drug candidates before initiating complex, expensive human trials. This approach seeks to provide a more efficient pathway for early-stage oncology research.
This preliminary research evaluated a potential cancer drug and drug combinations on clams to observe their effects on tumor growth, noting responses similar to those seen in human cells. The study was presented as part of a national science competition featuring 40 finalists.
The players
Iris Shen
A 17-year-old student researcher from The Woodlands who investigates novel animal models for cancer drug testing.
Regeneron
A biotechnology company that develops medications for oncology and other diseases and sponsors national science talent searches.
The details
The research used clams because they can develop a transmissible form of cancer called disseminated neoplasia. By observing how these organisms responded to drug combinations, the researcher aimed to measure potential effects on tumor growth. These responses were then compared to those previously observed in human cells to assess the viability of the clam model for future cancer studies.
Timeline
2017: Regeneron became the title sponsor of the science talent search.
2026: Iris Shen won third place in the competition.
Health Landscape
This work sits within the ongoing effort to replace or supplement traditional laboratory animals with more ethical and cost-effective models. It follows the pattern set by projects in the Regeneron Science Talent Search, which seeks to identify emerging student talent in medical science.
While this research offers a promising new direction for testing drug candidates, it remains in the preliminary experimental phase. Further investigation into biological mechanisms is required before these findings can impact human cancer treatment or care decisions.
The takeaway
This study underscores the potential for alternative animal models to improve the speed and ethics of cancer research. Follow future comparative studies to see if these clam-based findings hold up against established laboratory models for blood cancer.
Further reading
For more information on current developments in oncological research, visit the Cancer section.
Source note: This article includes information reported by The Times of India.
Live Poll
Should unconventional research methods be prioritized alongside traditional scientific laboratory models?
